Treatment of adrenocortical carcinoma: Contemporary outcomes

被引：2
作者：
Chen D.Y.T. [1 ]
Sosa R.E. [1 ]
Scherr D.S. [1 ]
机构：
[1] Department of Urology, New York-Presbyterian Hospital, Weill Cornell Medical Center, Starr 900, 525 East 68th Street, New York, 10021, NY
来源：
Current Urology Reports | 2004年 / 5卷 / 1期
关键词：
Adrenal Mass; Adrenal Metastasis; Adrenal Tumor; Adrenocortical Carcinoma; Laparoscopic Adrenalectomy;
D O I：
10.1007/s11934-004-0014-x
中图分类号：
学科分类号：
摘要：
Adrenocortical carcinoma is a rare cancer that historically has been associated with poor outcome. Throughout the past decades, growing experience has allowed better understanding of the natural history and optimal management of this cancer. Advances in imaging and aggressive surgical therapy have raised the outlook for recently diagnosed patients. Further improvements in survival will require more effective systemic therapy. © 2004, Current Science Inc.
引用
收藏
页码：65 / 72
页数：7
相关论文
共 51 条
[1]  
Icard P., Goudet P., Charpenay C., Et al., Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group, World J Surg, 25, pp. 891-897, (2001)
[2]  
Kendrick M.L., Lloyd R., Erickson L., Et al., Adrenocortical carcinoma: surgical progress or status quo?, Arch Surg, 136, pp. 543-549, (2001)
[3]  
Third National Cancer Survey Incidence Data, pp. 785-787, (1975)
[4]  
Wooten M.D., King D.K., Adrenal cortical carcinoma: epidemiology and treatment with mitotane and a review of the literature, Cancer, 72, pp. 3145-3155, (1993)
[5]  
Bukowski R.M., Klein E.A., Adrenal neoplasms, Comprehensive Textbook of Genitourinary Oncology, pp. 1073-1101, (2000)
[6]  
Wajchenberg B.L., Pereira M.A., Medonca B.B., Et al., Adrenocortical carcinoma: clinical and laboratory observations, Cancer, 88, pp. 711-736, (2000)
[7]  
Brennan M.F., Adrenocortical carcinoma, CA Cancer J Clin, 37, pp. 348-365, (1987)
[8]  
King D.R., Lack E.E., Adrenal cortical carcinoma: a clinical and pathologic study of 49 cases, Cancer, 44, pp. 239-244, (1979)
[9]  
Hogan T.F., Gilchrist K.W., Westring D.W., Citrin D.L., A clinical and pathological study of adrenocortical carcinoma: therapeutic implications, Cancer, 45, pp. 2880-2883, (1980)
[10]  
Karakousis C.P., Rao V., Moore R., Adrenal adenocarcinomas: histologic grading survival, J Surg Oncol, 29, pp. 105-111, (1985)
123456